[{"address1": "99 High Street", "address2": "30th Floor", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "617 300 8460", "website": "https://praxismedicines.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase III clinical trial for the treatment of essential tremor; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.", "fullTimeEmployees": 82, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marcio Silva De'Souza M.B.A.", "age": 44, "title": "President, CEO & Director", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 1179148, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy Edwin Kelly", "age": 51, "title": "CFO & Treasurer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 691583, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Nemiroff J.D.", "age": 44, "title": "General Counsel & Secretary", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 577338, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven  Petrou B.Sc. (Hons.), Ph.D.", "title": "Co-Founder & Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lauren  Mastrocola", "title": "VP of Finance & Principal Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karl  Hansen Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Kane", "title": "VP of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  McCue", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alyssa J. S. Wyant", "age": 49, "title": "Chief Regulatory & Quality Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan T. Sniecinski", "age": 42, "title": "Chief Business Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 79.54, "open": 80.56, "dayLow": 74.3, "dayHigh": 80.96, "regularMarketPreviousClose": 79.54, "regularMarketOpen": 80.56, "regularMarketDayLow": 74.3, "regularMarketDayHigh": 80.96, "payoutRatio": 0.0, "beta": 2.668, "forwardPE": -6.827681, "volume": 488717, "regularMarketVolume": 484706, "averageVolume": 365088, "averageVolume10days": 429500, "averageDailyVolume10Day": 429500, "bid": 74.27, "ask": 95.74, "bidSize": 1, "askSize": 2, "marketCap": 1388329728, "fiftyTwoWeekLow": 33.01, "fiftyTwoWeekHigh": 91.83, "priceToSalesTrailing12Months": 865.0029, "fiftyDayAverage": 76.5906, "twoHundredDayAverage": 61.9175, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1127076736, "profitMargins": 0.0, "floatShares": 14713966, "sharesOutstanding": 18637800, "sharesShort": 2622999, "sharesShortPriorMonth": 1901982, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.1407, "heldPercentInsiders": 0.0049799997, "heldPercentInstitutions": 1.17588, "shortRatio": 7.66, "shortPercentOfFloat": 0.1409, "impliedSharesOutstanding": 18637800, "bookValue": 21.515, "priceToBook": 3.4622357, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -151018000, "trailingEps": -9.17, "forwardEps": -10.91, "lastSplitFactor": "1:15", "lastSplitDate": 1701216000, "enterpriseToRevenue": 702.229, "enterpriseToEbitda": -6.89, "52WeekChange": 0.9101825, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 74.49, "targetHighPrice": 305.0, "targetLowPrice": 57.0, "targetMeanPrice": 160.45454, "targetMedianPrice": 150.0, "recommendationMean": 1.45455, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 357032000, "totalCashPerShare": 19.156, "ebitda": -163592992, "totalDebt": 1660000, "quickRatio": 10.865, "currentRatio": 10.957, "totalRevenue": 1605000, "debtToEquity": 0.434, "revenuePerShare": 0.106, "returnOnAssets": -0.39202, "returnOnEquity": -0.64342004, "grossProfits": -112908000, "freeCashflow": -48460376, "operatingCashflow": -99496000, "revenueGrowth": -0.355, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -188.19536, "financialCurrency": "USD", "symbol": "PRAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1740171903, "regularMarketTime": 1740171601, "exchange": "NMS", "messageBoardId": "finmb_409236524", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -6.349011, "regularMarketPrice": 74.49, "shortName": "Praxis Precision Medicines, Inc", "longName": "Praxis Precision Medicines, Inc.", "marketState": "POST", "priceEpsCurrentYear": -7.3762403, "fiftyDayAverageChange": -2.1006012, "fiftyDayAverageChangePercent": -0.027426358, "twoHundredDayAverageChange": 12.572498, "twoHundredDayAverageChangePercent": 0.20305242, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-16", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1602855000000, "postMarketChangePercent": 0.0, "postMarketPrice": 74.49, "postMarketChange": 0.0, "regularMarketChange": -5.050003, "regularMarketDayRange": "74.3 - 80.96", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 365088, "fiftyTwoWeekLowChange": 41.48, "fiftyTwoWeekLowChangePercent": 1.2565889, "fiftyTwoWeekRange": "33.01 - 91.83", "fiftyTwoWeekHighChange": -17.340004, "fiftyTwoWeekHighChangePercent": -0.18882722, "fiftyTwoWeekChangePercent": 91.01825, "earningsTimestampStart": 1741008600, "earningsTimestampEnd": 1741354200, "earningsCallTimestampStart": 1730898000, "earningsCallTimestampEnd": 1730898000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -9.17, "epsForward": -10.91, "epsCurrentYear": -10.09864, "displayName": "Praxis Precision Medicines", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]